Duvall Lab

About the PI

IMG_1672 (1)

Craig L. Duvall

Cornelius Vanderbilt Chair
Professor and Director of Undergraduate Studies,
Department of Biomedical Engineering
Vanderbilt University
Professor of Opthalmology and Visual Sciences,
Vanderbilt University School of Medicine

Office: ESB 444
Email Address: craig.duvall [at] vanderbilt.edu
Phone: (615)322-3598
Fax: (615)343-7919

Education:
Postdoctoral Training, Bioengineering, 2007-2009, University of Washington
Ph.D. Biomedical Engineering, 2007, Georgia Tech and Emory University
B.S. Biosystems and Agricultural Engineering, 2001, University of Kentucky

Biosketch:

Dr. Duvall completed his undergraduate studies at the University of Kentucky in 2001 and immediately started his doctoral studies in BME at Georgia Tech and Emory University. His Ph.D. work was jointly directed by Bob Guldberg, a mechanical/biomedical engineer from Georgia Tech, and Bob Taylor, a cardiologist from Emory. In 2007, Dr. Duvall joined the polymeric drug delivery technology labs of Patrick Stayton and Allan Hoffman in Bioengineering at the University of Washington for his NIH NRSA-funded postdoctoral fellowship. Based on the foundations built from these combined experiences, the Duvall Advanced Therapeutics Laboratory (ATL) was launched in the Vanderbilt Biomedical Engineering Department in 2010, and Dr. Duvall was promoted to Associate Professor in 2016 and Professor in 2019. The Duvall Advanced Therapeutics Laboratory specializes in design and application of smart polymer-based technologies for: (1) intracellular delivery of biological drugs such as peptides and nucleic acids, (2) proximity-activated targeting of drugs to sites of inflammation and matrix remodeling, and (3) long-term, “on-demand” drug release from localized depots. These delivery systems are designed to improve the therapeutic index of existing drugs and/or to serve as enabling technologies for manipulation of intracellular targets currently considered to be “undruggable”.

Dr. Duvall is a standing member of the National Institutes of Health Gene and Drug Delivery (GDD) grant review study section and has won awards such as the NSF CAREER Award, AHA Scientist Development Grant, Society for Biomaterials Young Investigator Award, BMES Cellular and Molecular Bioengineering Young Innovator Award, the Presidential Early Career Award for Scientists and Engineers (PECASE), and a Vanderbilt 2018 Chancellor Faculty Fellow.

Dr. Duvall has a passion for graduate student and postdoc training.  11 of his current and past graduate trainees have won NSF Graduate Research Fellowships, and 4 have received NIH predoctoral funding from training grants and fellowships.  Dr. Duvall has chaired 11 completed graduate research committees: M.S. students Martina Miteva and Rucha Joshi and Ph.D. students Chris Nelson, Kyle Hocking, Brian Evans, Kristin Poole, Kelsey Beavers, John Martin, Samantha Sarett, and Thomas Werfel.  Former students have gone on to successful positions in academia (Joshi, Nelson, Poole, Beavers, Martin, Werfel) and industry (Kavanaugh, Miteva, Hocking, Evans, Sarett), while postdocs have gone to industry (Li) and national laboratory (Dailing) positions. He maintains a lab of approximately 12 people, comprising ~10 Ph.D. students and 2-3 postdoctoral fellows / research faculty.  The lab collaborates intensively with faculty throughout the Vanderbilt Schools of Engineering and Medicine.

Outside of the lab, Dr. Duvall enjoys sports and outdoor activities, iaddition to spending quality time with his wife Gina and three children, Hayden, Henley, and Hudson.

Fam4

Fam3

Fam1

Fam2